Follow
Andrew D. Wagner
Andrew D. Wagner
Principal Scientist, Bristol Myers Squibb
Verified email at bms.com
Title
Cited by
Cited by
Year
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19
T Zvyaga, SY Chang, C Chen, Z Yang, R Vuppugalla, J Hurley, ...
Drug Metabolism and disposition 40 (9), 1698-1711, 2012
2472012
Methods and systems for quantification of peptides and other analytes
RP Grant, AD Wagner
US Patent 9,091,695, 2015
882015
Methods and systems for the quantitative analysis of biomarkers
RP Grant, AD Wagner, MK Morr, MR Patel
US Patent 7,935,921, 2011
552011
Studies to further investigate the inhibition of human liver microsomal CYP2C8 by the acyl-β-glucuronide of gemfibrozil
SM Jenkins, T Zvyaga, SR Johnson, J Hurley, A Wagner, R Burrell, ...
Drug metabolism and disposition 39 (12), 2421-2430, 2011
322011
Coupling laser diode thermal desorption with acoustic sample deposition to improve throughput of mass spectrometry–based screening
Z Haarhoff, A Wagner, P Picard, DM Drexler, T Zvyaga, W Shou
Journal of Biomolecular Screening 21 (2), 165-175, 2016
262016
Ultrafast mass spectrometry based bioanalytical method for digoxin supporting an in vitro P‐glycoprotein (P‐gp) inhibition screen
AD Wagner, JM Kolb, CC Özbal, JJ Herbst, TV Olah, HN Weller, ...
Rapid Communications in Mass Spectrometry 25 (9), 1231-1240, 2011
262011
Ultrahigh-throughput and chromatography-free bioanalysis of polar analytes with acoustic ejection mass spectrometry
A Wagner, J Zhang, C Liu, TR Covey, TV Olah, HBN Weller, WZ Shou
Analytical Chemistry 92 (19), 13525-13531, 2020
242020
Development of a high‐throughput mass spectrometry based analytical method to support an in vitro OATP1B1 inhibition screening assay
AD Wagner, L Elkin, K Mosure, L Gallagher, LK Stavola, MG Soars, ...
Rapid Communications in Mass Spectrometry 30 (15), 1787-1796, 2016
62016
Methods and Systems for the Quantitative Analysis of Biomarkers
RP Grant, AD Wagner, MK Morr, MR Patel
US Patent App. 13/080,014, 2011
62011
Quantitative LC-MS/MS Analysis of Engodenous Biomarkers for Clinical Diagnosi in Endrocrinology
M Morr, A Wagner, M Patel, R Grant
54 th ASMS Conference Proceedings, 2006
32006
Direct Online SPE‐MS for High‐Throughput Analysis in Drug Discovery
AD Wagner, WZ Shou
High‐Throughput Mass Spectrometry in Drug Discovery, 121-142, 2023
12023
LEVERAGING A PANEL OF HIGH-THROUGHPUT (HT) TRANSPORTER INHIBITION ASSAYS TO DRIVE DECISION-MAKING AND ENHANCE ADMET KNOWLEDGE
LL Elkin, ME Cvijic, H Tang, K Mosure, DR Shen, YH Han, A Wagner, ...
DRUG METABOLISM REVIEWS 45, 254-254, 2014
2014
DEVELOPMENT OF A HIGH THROUGHPUT 384-WELL MASS SPECTROMETRY-BASED OATP1B1 INHIBITION ASSAY TO DRIVE INFORMED DECISION MAKING IN EARLY DISCOVERY
L Pajor, K Mosure, B Robertson, L Elkin, A Wagner, W Shou, MG Soars
DRUG METABOLISM REVIEWS 44, 148-148, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–13